212 related articles for article (PubMed ID: 35902588)
1. Aberrant androgen action in prostatic progenitor cells induces oncogenesis and tumor development through IGF1 and Wnt axes.
Kim WK; Olson AW; Mi J; Wang J; Lee DH; Le V; Hiroto A; Aldahl J; Nenninger CH; Buckley AJ; Cardiff R; You S; Sun Z
Nat Commun; 2022 Jul; 13(1):4364. PubMed ID: 35902588
[TBL] [Abstract][Full Text] [Related]
2. Stromal androgen signaling acts as tumor niches to drive prostatic basal epithelial progenitor-initiated oncogenesis.
Hiroto A; Kim WK; Pineda A; He Y; Lee DH; Le V; Olson AW; Aldahl J; Nenninger CH; Buckley AJ; Xiao GQ; Geradts J; Sun Z
Nat Commun; 2022 Nov; 13(1):6552. PubMed ID: 36323713
[TBL] [Abstract][Full Text] [Related]
3. The androgen receptor can signal through Wnt/beta-Catenin in prostate cancer cells as an adaptation mechanism to castration levels of androgens.
Schweizer L; Rizzo CA; Spires TE; Platero JS; Wu Q; Lin TA; Gottardis MM; Attar RM
BMC Cell Biol; 2008 Jan; 9():4. PubMed ID: 18218096
[TBL] [Abstract][Full Text] [Related]
4. Androgen receptor with short polyglutamine tract preferably enhances Wnt/β-catenin-mediated prostatic tumorigenesis.
He Y; Mi J; Olson A; Aldahl J; Hooker E; Yu EJ; Le V; Lee DH; Kim WK; Robins DM; Geradts J; Sun Z
Oncogene; 2020 Apr; 39(16):3276-3291. PubMed ID: 32089544
[TBL] [Abstract][Full Text] [Related]
5. Androgen signaling is a confounding factor for β-catenin-mediated prostate tumorigenesis.
Lee SH; Luong R; Johnson DT; Cunha GR; Rivina L; Gonzalgo ML; Sun Z
Oncogene; 2016 Feb; 35(6):702-14. PubMed ID: 25893287
[TBL] [Abstract][Full Text] [Related]
6. Multifaceted interaction between the androgen and Wnt signaling pathways and the implication for prostate cancer.
Terry S; Yang X; Chen MW; Vacherot F; Buttyan R
J Cell Biochem; 2006 Oct; 99(2):402-10. PubMed ID: 16741972
[TBL] [Abstract][Full Text] [Related]
7. Androgen deprivation induces double-null prostate cancer via aberrant nuclear export and ribosomal biogenesis through HGF and Wnt activation.
Kim WK; Buckley AJ; Lee DH; Hiroto A; Nenninger CH; Olson AW; Wang J; Li Z; Vikram R; Adzavon YM; Yau TY; Bao Y; Kahn M; Geradts J; Xiao GQ; Sun Z
Nat Commun; 2024 Feb; 15(1):1231. PubMed ID: 38336745
[TBL] [Abstract][Full Text] [Related]
8. Aberrant activation of hepatocyte growth factor/MET signaling promotes β-catenin-mediated prostatic tumorigenesis.
Aldahl J; Mi J; Pineda A; Kim WK; Olson A; Hooker E; He Y; Yu EJ; Le V; Lee DH; Geradts J; Sun Z
J Biol Chem; 2020 Jan; 295(2):631-644. PubMed ID: 31819003
[TBL] [Abstract][Full Text] [Related]
9. Conditional expression of the androgen receptor induces oncogenic transformation of the mouse prostate.
Zhu C; Luong R; Zhuo M; Johnson DT; McKenney JK; Cunha GR; Sun Z
J Biol Chem; 2011 Sep; 286(38):33478-88. PubMed ID: 21795710
[TBL] [Abstract][Full Text] [Related]
10. Activation of β-Catenin Cooperates with Loss of Pten to Drive AR-Independent Castration-Resistant Prostate Cancer.
Patel R; Brzezinska EA; Repiscak P; Ahmad I; Mui E; Gao M; Blomme A; Harle V; Tan EH; Malviya G; Mrowinska A; Loveridge CJ; Rushworth LK; Edwards J; Ntala C; Nixon C; Hedley A; Mackay G; Tardito S; Sansom OJ; Leung HY
Cancer Res; 2020 Feb; 80(3):576-590. PubMed ID: 31719098
[TBL] [Abstract][Full Text] [Related]
11. Roles and regulation of Wnt signaling and beta-catenin in prostate cancer.
Verras M; Sun Z
Cancer Lett; 2006 Jun; 237(1):22-32. PubMed ID: 16023783
[TBL] [Abstract][Full Text] [Related]
12. Noncanonical Wnt signaling mediates androgen-dependent tumor growth in a mouse model of prostate cancer.
Takahashi S; Watanabe T; Okada M; Inoue K; Ueda T; Takada I; Watabe T; Yamamoto Y; Fukuda T; Nakamura T; Akimoto C; Fujimura T; Hoshino M; Imai Y; Metzger D; Miyazono K; Minami Y; Chambon P; Kitamura T; Matsumoto T; Kato S
Proc Natl Acad Sci U S A; 2011 Mar; 108(12):4938-43. PubMed ID: 21383160
[TBL] [Abstract][Full Text] [Related]
13. Interplay Between SOX9, Wnt/β-Catenin and Androgen Receptor Signaling in Castration-Resistant Prostate Cancer.
Khurana N; Sikka SC
Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31027362
[TBL] [Abstract][Full Text] [Related]
14. Increased Akt signaling resulting from the loss of androgen responsiveness in prostate cancer.
Dulinska-Litewka J; McCubrey JA; Laidler P
Curr Med Chem; 2013; 20(1):144-57. PubMed ID: 23033951
[TBL] [Abstract][Full Text] [Related]
15. Crosstalk between the androgen receptor and beta-catenin in castrate-resistant prostate cancer.
Wang G; Wang J; Sadar MD
Cancer Res; 2008 Dec; 68(23):9918-27. PubMed ID: 19047173
[TBL] [Abstract][Full Text] [Related]
16. Modulation of the canonical Wnt activity by androgen signaling in prostate epithelial basal stem cells.
Horton C; Liu Y; Wang J; Green J; Tsyporin J; Chen B; Wang ZA
Stem Cell Reports; 2023 Jun; 18(6):1355-1370. PubMed ID: 37172587
[TBL] [Abstract][Full Text] [Related]
17. Stromal androgen and hedgehog signaling regulates stem cell niches in pubertal prostate development.
Olson AW; Le V; Wang J; Hiroto A; Kim WK; Lee DH; Aldahl J; Wu X; Kim M; Cunha GR; You S; Sun Z
Development; 2021 Oct; 148(19):. PubMed ID: 34427305
[TBL] [Abstract][Full Text] [Related]
18. Androgen signaling is essential for development of prostate cancer initiated from prostatic basal cells.
He Y; Hooker E; Yu EJ; Cunha GR; Liao L; Xu J; Earl A; Wu H; Gonzalgo ML; Sun Z
Oncogene; 2019 Mar; 38(13):2337-2350. PubMed ID: 30510232
[TBL] [Abstract][Full Text] [Related]
19. Androgen-induced PSA expression requires not only activation of AR but also endogenous IGF-I or IGF-I/PI3K/Akt signaling in human prostate cancer epithelial cells.
Liu X; Choi RY; Jawad SM; Arnold JT
Prostate; 2011 May; 71(7):766-77. PubMed ID: 21031436
[TBL] [Abstract][Full Text] [Related]
20. Effects of WNT/beta-catenin pathway activation on signaling through T-cell factor and androgen receptor in prostate cancer cell lines.
Cronauer MV; Schulz WA; Ackermann R; Burchardt M
Int J Oncol; 2005 Apr; 26(4):1033-40. PubMed ID: 15753999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]